Literature DB >> 20970657

Chronic kidney disease after lung transplantation: incidence, risk factors, and treatment.

M Paradela de la Morena1, M De La Torre Bravos, R Fernández Prado, M Delgado Roel, J A García Salcedo, E Fieira Costa, D González Rivas, J M Borro Maté.   

Abstract

OBJECTIVE: The purpose of this study was to determinate the incidence of risk factors and therapeutic strategies for chronic kidney disease (CKD) among our lung transplant recipients. We also analyzed the association with 1-, 2-, and 5-years mortality after lung transplantation. PATIENTS AND METHODS: This descriptive, retrospective study of 161 patients undergoing lung transplantations between June 1999 and December 2008 assessed the incidence and severity of CKD, following the updated guidelines of the National Kidney Foundation. Using univariate and multivariate analysis, we considered the impact of multiple factors on kidney function. The relationship between CDK and mortality was assessed using Kaplan-Meier method.
RESULTS: Among 161 patients, 68.6% developed CKD. The decrease in glomerular filtration rate (GFR) was sharper in the first year. Upon, multivariate analysis, the factors most strongly associated with this decrease included advanced age (odds ratio [OR]=2.0; P<.001) and cytomegalovirus (CMV) infection (OR=2.2; P=.045). Factors significantly associated in the univariate analysis were pretransplantation GFR, pulmonary disease, initial therapy containing tacrolimus, and conversion to mycophenolate mofetil. Recipients who developed CKD at 1 year after transplantation showed a strong association with mortality (P=.001).
CONCLUSIONS: We observed a biphasic decrease in GFR, characterized by a rapid decrease in the first year. The development of CKD during this period was associated with an increased risk of death. To introduce renoprotective strategies, we must identify early predictors of decreasing renal function.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20970657     DOI: 10.1016/j.transproceed.2010.05.064

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

Review 1.  Lung transplantation: a treatment option in end-stage lung disease.

Authors:  Marc Hartert; Omer Senbaklavacin; Bernhard Gohrbandt; Berthold M Fischer; Roland Buhl; Christian-Friedrich Vahld
Journal:  Dtsch Arztebl Int       Date:  2014-02-14       Impact factor: 5.594

Review 2.  Immunosuppression in Lung Transplantation.

Authors:  Joelle Nelson; Elisabeth Kincaide; Jamie Schulte; Reed Hall; Deborah Jo Levine
Journal:  Handb Exp Pharmacol       Date:  2022

Review 3.  Non-pulmonary complications after lung transplantation: Part I.

Authors:  Rohan Kanade; Aditya Kler; Amit Banga
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-10-08

4.  Successful combined second redo lung-kidney transplantation in a patient who developed end-stage renal disease after a previous lung transplantation.

Authors:  Jin-Hee Noh; Dohyung Kim; Woo Hyun Cho; Hye Ju Yeo
Journal:  Korean J Transplant       Date:  2020-09-30

5.  High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury.

Authors:  M A Sikma; C C Hunault; E A van de Graaf; M C Verhaar; J Kesecioglu; D W de Lange; J Meulenbelt
Journal:  Eur J Clin Pharmacol       Date:  2017-01-28       Impact factor: 2.953

6.  Acute Kidney Injury after Lung Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Ploypin Lertjitbanjong; Charat Thongprayoon; Wisit Cheungpasitporn; Oisín A O'Corragain; Narat Srivali; Tarun Bathini; Kanramon Watthanasuntorn; Narothama Reddy Aeddula; Sohail Abdul Salim; Patompong Ungprasert; Erin A Gillaspie; Karn Wijarnpreecha; Michael A Mao; Wisit Kaewput
Journal:  J Clin Med       Date:  2019-10-17       Impact factor: 4.241

Review 7.  Kidney disease in non-kidney solid organ transplantation.

Authors:  Kurtis J Swanson
Journal:  World J Transplant       Date:  2022-08-18

Review 8.  Kidney Disease after Heart and Lung Transplantation.

Authors:  Carlos M Zapata; Hassan N Ibrahim
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-09-06

9.  A Safety and Tolerability Study of Thin Film Freeze-Dried Tacrolimus for Local Pulmonary Drug Delivery in Human Subjects.

Authors:  Sawittree Sahakijpijarn; Moeezullah Beg; Stephanie M Levine; Jay I Peters; Robert O Williams
Journal:  Pharmaceutics       Date:  2021-05-13       Impact factor: 6.321

Review 10.  BK Virus: A Cause for Concern in Thoracic Transplantation?

Authors:  Markus J Barten; Andreas Zuckermann
Journal:  Ann Transplant       Date:  2018-05-11       Impact factor: 1.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.